Author

Matthew C. Metcalf

Institute for Bioscience and Biotechnology ResearchORCID 0000-0001-7705-4574Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander K. AndrianoviD· 1 shared Alexander MariniD· 1 shared Brian G. PierceiD· 1 shared Dong-Xiu Zhang· 1 shared Edwin Pozharski· 1 shared Eric A. TothiD· 1 shared Kinlin L. ChaoiD· 1 shared Liudmila Kulakova· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alexander K. AndrianovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Incorporation of native HCV E1E2 into a nanoparticle vaccine platform

Liudmila Kulakova, Sarah Jeong, Dong-Xiu Zhang, Xiaoran Shang, Kinlin L. Chao, Alexander Marin, Matthew C. Metcalf, Tagide deCarvalho, Edwin Pozharski, Yuxing Li, Brian G. Pierce, Alexander K. Andrianov, Eric A. Toth, Thomas R. Fuerst

This paper develops a nanoparticle vaccine platform incorporating native HCV E1E2 to enhance immunogenicity, showing improved neutralizing antibody responses compared to subunit vaccines.

bioRxiv · Aug 6, 2026 · PreprintMicrobiology